-
Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D, 2017: Antibody-based assay discriminates Zika virus infection from other flaviviruses[J]. Proc Natl Acad Sci USA, 114, 8384-8389. doi: 10.1073/pnas.1704984114
-
Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, Nachbagauer R, Foster GA, Krysztof D, Tortorella D, Stramer SL, Garcia-Sastre A, Krammer F, Lim JK, 2017: Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity[J]. Science, 356, 175-180. doi: 10.1126/science.aal4365
-
Collins MH, McGowan E, Jadi R, Young E, Lopez CA, Baric RS, Lazear HM, de Silva AM, 2017: Lack of durable crossneutralizing antibodies against Zika virus from dengue virus infection[J]. Emerg Infect Dis, 23, 773-781. doi: 10.3201/eid2305.161630
-
David S, Angela S, Derek RS, Emelissa M, Nicole B, Charlene R, Leanne S, Kimberly H, Alyssia R, Maya T-A, Kai M, Kristina D, Elizabeth G, Joanne H, Rhonda M, Sharla B, Michael D, 2017: Evaluation of 5 commercially available Zika virus immunoassays[J]. Emerg Infect Dis, 23, 1577-. doi: 10.3201/eid2309.162043
-
de Vasconcelos ZFM, Azevedo RC, Thompson N, Gomes L, Guida L, Moreira MEL, 2018: Challenges for molecular and serological ZIKV infection confirmation[J]. Childs Nerv Syst, 34, 79-84. doi: 10.1007/s00381-017-3641-5
-
Guzman MG, Alvarez M, Halstead SB, 2013: Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibodydependent enhancement of infection[J]. Arch Virol, 158, 1445-1459. doi: 10.1007/s00705-013-1645-3
-
Jelsma T, van der Wal FJ, Fijten H, Dailly N, van Dijk E, Loeffen WL, 2017: Pre-screening of crude peptides in a serological beadbased suspension array[J]. J Virol Methods, 247, 114-118. doi: 10.1016/j.jviromet.2017.05.008
-
L'Huillier AG, Hamid-Allie A, Kristjanson E, Papageorgiou L, Hung S, Wong CF, Stein DR, Olsha R, Goneau LW, Dimitrova K, Drebot M, Safronetz D, Gubbay JB, 2017: Evaluation of euroimmun anti-Zika virus IgM and IgG enzyme-linked immunosorbent assays for Zika virus serologic testing[J]. J Clin Microbiol, 55, 2462-2471. doi: 10.1128/JCM.00442-17
-
Platt DJ, Miner JJ, 2017: Consequences of congenital Zika virus infection[J]. Curr Opin Virol, 27, 1-7.
-
Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J, 2016: Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus[J]. Proc Natl Acad Sci USA, 113, 7852-7857. doi: 10.1073/pnas.1607931113
-
Shan C, Xie X, Ren P, Loeffelholz MJ, Yang Y, Furuya A, Dupuis AP Ⅱ, Kramer LD, Wong SJ, Shi PY, 2017: A rapid Zika diagnostic assay to measure neutralizing antibodies in patients[J]. EBioMedicine, 17, 157-162. doi: 10.1016/j.ebiom.2017.03.006
-
Wong SJ, Furuya A, Zou J, Xie X, Dupuis AP Ⅱ, Kramer LD, Shi PY, 2017: A multiplex microsphere immunoassay for Zika virus diagnosis[J]. EBioMedicine, 16, 136-140. doi: 10.1016/j.ebiom.2017.01.008
-
Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung'u T, Ruxrungtham K, Sanchez J, Brander C, Chung RT, O'Connor KC, Walker B, Larman HB, Elledge SJ, 2015: Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome[J]. Science, 348, aaa0698-. doi: 10.1126/science.aaa0698